openPR Logo
Press release

Personalized Cancer Vaccines Market and Clinical Innovation Outlook 2022

06-30-2017 09:42 AM CET | Health & Medicine

Press release from: Kuick Resarch

Personalized Cancer Vaccines Market and Clinical Innovation

Oncological segment has gained a great momentum with the advent of modern technologies and the better equipped sequencing methodology. Over the past years, there has been gradual paradigm shift from traditional medicine and accelerated acceptance towards the precision medication. Physicians are opting for the personalization of the medicines according to the genomic makeup of the patient.

Download Report:

https://www.kuickresearch.com/report-personalized-cancer-vaccines-market-and-clinical-innovation-outlook-2022.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

"Personalized Cancer Vaccines Market and Clinical Innovation Outlook 2022" Table of Contents

1. Personalized Vaccine: Trail Towards Cancer
1.1 Prologue to Personalized Cancer Immunotherapy
1.2 Advent of Personalized Cancer Vaccine

2. Perception of Personalized Vaccinomics
2.1 Genetic Heterogeneity by HLA System
2.2 Genesis of Tumor Neoantigens

3. Identification of Tumor Neoantigens
3.1 Conventional Methodologies
3.2 Next Genome Sequencing Approach

4. Development of Personalized Vaccines
4.1 Development Process of Personal Cancer Vaccine
4.2 Economic Aspects of Personalized Cancer Vaccine

5. Mechanism of Personalized Vaccines
5.1 Rationale of Personal Cancer Vaccine
5.2 Neoantigens and Immune Interactions

6. Application of Neoantigens in Therapeutics
6.1 Adoptive T Cell Therapy
6.2 Checkpoint Blockade

7. Categories of Personalized Cancer Vaccines
7.1 Personalized Peptide Vaccination (PPV)
7.2 DNA Cancer Vaccines
7.3 RNA Based Vaccines
7.4 Dendritic Cell Vaccines
7.5 Whole Tumor Cell Vaccines
7.6 Recombinant Virus Vaccines


8. Biomarkers for Personalized Vaccines
8.1 Pharmacogenomic Biomarkers
8.2 Prognostic and Predictive Biomarkers
8.3 Immune Checkpoint Biomarkers

9. Personalized Vaccines for Varied Cancers
9.1 Melanoma
9.2 Lung Cancer
9.3 Breast Cancer
9.4 Colorectal Cancer
9.5 Leukemia
9.6 Prostate cancer
9.7 Cervical Cancer
9.8 Gastric Cancer
9.9 Brain Tumor
9.10 Renal Cancer

10. Pharmacogenomics of Personalization
10.1 Pharmacogenomics towards Genomic Polymorphism
10.2 Somatic Mutations in Cancer Pharmacogenomics
10.3 Applications of Pharmacogenomics

11. Personalized Vaccines Market Overview
11.1 Market Trends Towards Therapeutic Personalization
11.2 Mergers and Acquisitions for Personalized Therapy

12. Global Personalized Vaccines Market Dynamics
12.1 Personalization Growth Drivers
12.1.1 Increasing Cancer Incidences
12.1.2 Cancer Heterogenetic Environment
12.1.3 High Level of Specificity
12.1.4 Government Initiatives
12.1.5 Reduced Genome Sequencing Cost and Time
12.1.6 Sustained Level of Innovation
12.2 Personalization Major Challenges

13. Global Personalized Cancer Vaccines Market Future Aspects

14. Competitive Landscape
14.1 Advaxis Inc.
14.2 Avax Technologies
14.3 BioNtech
14.4 Celldex
14.5 Genentech Inc.
14.6 Genocea
14.7 ISA Pharmaceuticals
14.8 Merck and Co.
14.9 Moderna
14.10 Neon Therapeutics

Figure 1-1: Categorization of the Cancer Immunotherapeutics Towards Cancer Vaccines
Figure 1-2: Illustration of Advantages Provided by the Targeting Neoantigens
Figure 2-1: Distinguishing Features of Driver and Passenger Gene Mutations
Figure 3-1: Identification of Tumor Antigens by Conventional Approach
Figure 3-2: Number of Mutation Derived Neoantigens in Human Cancer
Figure 3-3: Identification of Tumor Specific Neoantigens by Next Generation Sequencing
Figure 4-1: Illustration of Development of personalized Cancer Vaccines
Figure 4-2: Estimated Cost for Cancer Cell’s Genome Sequencing (US$)
Figure 4-3: Estimated Economic (US$) and Timeline (Weeks) Projections of Personalized Cancer Vaccine
Figure 5-1: Illustration of Development of Personalized Cancer Vaccines
Figure 5-2: Immune Stimulation by T-Cells with Personalized Cancer Vaccine
Figure 5-3: Immune Response Stimulation by B Cells with Personalized Cancer Vaccines
Figure 6-1: Route of Action of Adoptive T-Cell Mechanism in Individual
Figure 6-2: Clinical Aspects of Tumor Infiltrating T Cells in Cancer
Figure 6-3: Typical Mechanism of T Cell Activation via Signal Binding
Figure 6-4: Schematic Representation of Evolution of CARs Design
Figure 6-5: Mechanism of Cell Checkpoint Blockade in Cancer Vaccines
Figure 6-6: Mechanism of Cytotoxic T-Lymphocyte Associated Antigen-4 (CTLA-4)
Figure 6-7: Mechanism of PDL-1 Checkpoint Blockade in Tumor Cells
Figure 7-1: Differences between Conventional and Personalized Peptide Vaccine
Figure 7-2: The Representation of Template of a Polypeptide DNA Vaccine
Figure 7-3: Principle Structure of Synthetic m-RNA Developed with Specific Antigen
Figure 7-4: Representation of Ex-Vivo Preparation of Dendritic Cell based Vaccines
Figure 7-5: The Tumor Microenvironment Suppresses Efficacy by DC based Vaccines
Figure 7-6: Mechanism of Personalized Autologous Whole Tumor Cancer Vaccine
Figure 7-7: Representation of Replicative Virus Encoding a HSP Gene for Antitumor Activity
Figure 8-1: Illustration of Various Types of Biomarkers in Personalized Medicine
Figure 8-2: Roadmap of Development of Predictive Biomarkers
Figure 8-3: High Throughput Immune Assessment for Biomarker Discovery
Figure 9-1: Alterations in Mechanism of Cell Cycle Control of CDKN2A
Figure 9-2: Illustration of Targetable Oncogenic Drivers in Non-Small Lung Cancer
Figure 9-3: Personalized Strategies to Attain the Target of Interest in Acute Myeloid Leukemia
Figure 9-4: Prevalence of Cervical Cancer in Women in Developed and Developing Countries
Figure 9-5: Proportion of Genetic Abnormalities Present in Gastric Cancer
Figure 9-6: Classification of Gliomas into Four Grades Based as WHO Classification
Figure 9-7: Illustration of Loss of VHL Expression Leads to Renal Cell Carcinoma
Figure 10-1: Demonstration of Genomic Polymorphism in Pharmacogenomics
Figure 10-2: The Sources of Pharmacological and Pharmacogenetic Variability’s
Figure 10-3: Applications of Pharmacogenomics in Cancer Precision Medicines
Figure 11-1: Personalized Cancer Vaccine Market Opportunity Assessment (US$ Million), 2017-2022
Figure 11-2: Representation of the Commercial Oncological Trials by Segment
Figure 12-1: Representation of Growth Drivers in Personalized Cancer Vaccines
Figure 12-2: Illustrations of the Reduced Sequencing Cost of Human Genome
Figure 12-3: Major Challenges faced by the Personalized Cancer Vaccines

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Personalized Cancer Vaccines Market and Clinical Innovation Outlook 2022 here

News-ID: 603449 • Views:

More Releases from Kuick Resarch

Lumakras Drug Clinical Insight and Sales Forecast 2026
Lumakras Drug Clinical Insight and Sales Forecast 2026
"Lumakras Drug Clinical Insight and Sales Forecast 2026" Report Highlights: * NSCLC Targeting Lumakras Market Opportunity (US$ Million) * Colorectal Cancer Targeting Lumakras Market Opportunity (US$ Million) * Pharmacokinetics of Lumakras (Sotorasib) * Dosage, Patent and Price Analysis * Lumakras Ongoing Clinical Trials * Global KRAS Protein Inhibitors Clinical Trials Download Report: https://www.kuickresearch.com/report-lumakras-sotorasib-sales-forecast-fda-approved-kras-inhibitor-clinical-trials-non-small-cell-lung-cancer-nslc-g12c-mutation-c30h30f2n6o3-ras-gtpase The rising burden of cancer and the increasing cancer mortality rates possesses an unmet need for the development of novel therapies in the management
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
"Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026" Report Highlights: * Global EZH2 Inhibitor Market Opportunity > US$ 1.2 Billion by 2026 * Tazverik (Tazemetostat) First Approved EZH2 Inhibitor Drug * Dosage, Price and Sales Analysis of Tazverik * Tazverik Sales Opportunity > US$ 900 Million by 2026 * Tazverik Sales Forecast 2021 Till 2026 * EZH2 Inhibitor Clinical Pipeline Overview By Company, Indication and Phase * EZH2 Inhibitor in Clinical Trials: 7 Drugs Download
Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028
Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Tr …
"Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028" Report Highlights: * Global Bispecific Antibody Market Opportunity: > US$ 20 Billion * Global Bispecific Antibody Market Growth Rate: 100% CAGR (2016 -2021) * Approved Bispecific Antibodies In Market: 4 Antibodies * Detailed Market Sales and Trends Insight Till 2028 * Quarterly and Yearly Sales Insight Of Approved Antibodies Till Q1 2022 * Global and Regional Market Analysis * Approved Drug Sales
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and C …
"Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026" Report Highlights: * Global FGFR Inhibitors Market Opportunity: > USD 4 Billion by 2026 * Role of FGFR Inhibitors in Cancer Therapy * Global FGFR Market Assessment (US$) by Region and Cancer Type Clinical and Sales Insight on Approved FGFR Inhibitors: 3 (Belvesra, Pemazyre and Truseltiq) * Dosage and Drug Price Insight on Approved FGFR Inhibitors * Comprehensive Clinical Trials Insight

All 5 Releases


More Releases for Figure

Floralite - Reduce Fat & Get Attractive Figure How To Buy!
Floralite Have you been working on your eating routine without seeing the results that you are anticipating? There is indeed thing called Floralite diet pills. Advantages of Floralite Floralite One of various things to esteem about this thing is that it's made expressly for the Floralite diet. That is an epic notwithstanding considering the way that when you use a thing that is custom fitted to work with the movements
THE WORLD'S MOST CONTROVERSIAL ACTION FIGURE...EVER!
FOR IMMEDIATE RELEASE THE WORLD'S MOST CONTROVERSIAL ACTION FIGURE...EVER! Contact: William Hirsch - Schlock Toys @ +1-949-677-9353 or DocSchlock@SchlockToys.com Featured on Tomi with Fox News host Tomi Lahren! SCHLOCK TOYS join forces with Kickstarter to Make Toys Great Again! The Kickstarter campaign page can be found HERE: https://www.kickstarter.com/projects/schlocktoys/collectors-edition-talking-trump-2020-man-of-action-figure/description “What a great message to be sent, and I think Trump himself would love this and that he’d be excited about it!” - Tomi Lahren, Fox News “You
Macarons Market Latest Sales Figure Signals More Opportunities Ahead
Global Macarons Sales Market(Sales,Revenue and competitors Analysis of Major Market)from 2014-2026 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Macarons Market. Some of the key players profiled in the study are La Dure,
Global Womens Figure Skates Market Growth 2019-2024
LP INFORMATION offers a latest published report on Womens Figure Skates Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Womens Figure Skates market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.
Figure Skating Equipment Market Report 2018: Segmentation by Type (Figure Skate …
Global Figure Skating Equipment market research report provides company profile for SP-Teri, Graf Skate, Riedell Shoes, Roces, American Athletic, Rollerblade, Winnwell, Dongguan King Line, Jackson Ultima, HD Sports(MK Blades, John Wilson), Edea, Risport Skates, Paramount Skates and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY
Long-lasting Performance Improvement with Key Figure Analysis
Vienna/Reutlingen, October 17, 2012 – Manz, a leading high-tech mechanical engineering company, is optimizing its processes in strategic sourcing in order to recognize the risks and potential associated with each supplier early on so that the sourcing department can react to them in time. POOL4TOOL’s customized eSolutions localize and analyze key figures that are relevant to the decision making process, and displays these figures in a comprehensive and transparent way.